Advanced male breast cancer treatment with the LH‐RH analogue buserelin alone or in combination with the antiandrogen flutamide

Cancer

Volumn 62, Issue 3, 1988, Pages 474-478

  Doberauer, Claus ^a   Niederle, Norbert ^a   Schmidt, Carl G ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; FLUTAMIDE;

BREAST CANCER; CLINICAL ARTICLE; HOT FLUSH; HUMAN; IMPOTENCE; INTRANASAL DRUG ADMINISTRATION; LIBIDO; MALE; MALE BREAST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SIDE EFFECT;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; BUSERELIN; ESTRADIOL; FLUTAMIDE; FOLLICLE STIMULATING HORMONE; HUMAN; LUTEINIZING HORMONE; MALE; MIDDLE AGE; TESTOSTERONE;

EID: 0023772713     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19880801)62:3<474::AID-CNCR2820620305>3.0.CO;2-2     Document Type: Article

References (21)

1. Effect of orchiectomy on skeletal metastases from cancer of the male breast
2. The role of orchiectomy in the management of advanced male breast cancer
3. The sex hormone profile of male patients with breast cancer
4. Plasma estrogens and androgens in male breast cancer
5. Inhibition of prostate tumor growth in two rat models by chronic administration of D‐Trp6 analogue of luteinizing hormone‐releasing hormone
6. Paradoxical effects of D‐Trp6‐luteinizing hormone‐releasing hormone on the hypothalamic‐pituitary‐gonadal axis in immature female rats
7. Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone‐releasing hormone agonists
8. Treatment with a luteinizing hormone‐releasing hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer
9. Disease flare induced by D‐Trp6‐LHRH analogue in patients with metastatic prostatic cancer
10. Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone‐releasing hormone agonists in the treatment of prostate cancer
11. Combined treatment with flutamide and surgical or medical (LHRH agonist) castration in metastatic prostatic cancer
12. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
13. Clinical correlations of steroid receptors and male breast cancer
14. The treatment of cancer, especially inoperable cancer, of the male breast by ablative surgery (orchiectomy, adrenalectomy, and hypophysectomy) and hormone therapy (estrogens and corticosteroids). An analysis of 42 patients
15. Hormonal therapy for metastatic male breast cancer
16. Male breast cancer: A review
17. Use of tamoxifen in advanced male breast cancer
18. High‐dose medroxyprogesterone acetate in advanced male breast cancer
19. Cyproterone acetate in the treatment of metastatic cancer of the male breast
20. Metastatic breast cancer in males. Assessment of endocrine therapy
21. Role of aminoglutethimide in male breast cancer